AM/DY- Manager-Analytical Development

Jubilant Pharma Limited is a global integrated pharmaceutical company that offers a diverse range of products and services to customers worldwide. The business is structured into two key segments: Specialty Pharmaceuticals and Generics & APIs. In the Specialty Pharmaceuticals segment, the company specializes in Radiopharmaceuticals, Contract Manufacturing of Sterile Injectable, Non-sterile & Allergy Therapy Products. The Generics & APIs segment focuses on Solid Dosage Formulations & Active Pharmaceutical Ingredients. Jubilant Generics (JGL) is a wholly-owned subsidiary of Jubilant Pharma, with Research & Development units located in Noida and Mysore, India. JGL operates manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, dedicated to APIs and Dosage manufacturing. The Mysore manufacturing site, spread over 69 acres, is USFDA approved and produces APIs for global distribution, with a focus on Lifestyle driven Therapeutic Areas such as CVS and CNS. The Roorkee facility is a state-of-the-art site approved by multiple regulatory bodies including USFDA, Japan PMDA, UK MHRA, TGA, WHO, and Brazil ANVISA, catering to B2B markets in EU, Canada, and emerging markets. Backward-integrated manufacturing units are supported by a team of 500 research and development professionals based in Noida and Mysore. The R&D team focuses on developing new products in API, Solid Dosage Formulations, Sterile Injectable products, Semi-Solids like Ointments, Creams, and Liquids. The company conducts all BA/BE studies in-house at an 80 Bed facility with global regulatory accreditations. JGL's Regulatory Affairs & IPR professionals manage a unique portfolio of patents and product filings for regulatory and non-regulatory markets. Jubilant Pharma has witnessed consistent revenue growth, with revenue reaching INR 53,240 Million in the Financial Year 2018-19, compared to INR 39,950 Million in the Financial Year 2017-18. For more information about the organization, please visit www.jubilantpharma.com.,